Mendoza-Rodríguez, M.G.; Sánchez-Barrera, C.Á.; Callejas, B.E.; García-Castillo, V.; Beristain-Terrazas, D.L.; Delgado-Buenrostro, N.L.; Chirino, Y.I.; León-Cabrera, S.A.; Rodríguez-Sosa, M.; Gutierrez-Cirlos, E.B.;
et al. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. Int. J. Mol. Sci. 2020, 21, 2130.
https://doi.org/10.3390/ijms21062130
AMA Style
Mendoza-Rodríguez MG, Sánchez-Barrera CÁ, Callejas BE, García-Castillo V, Beristain-Terrazas DL, Delgado-Buenrostro NL, Chirino YI, León-Cabrera SA, Rodríguez-Sosa M, Gutierrez-Cirlos EB,
et al. Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. International Journal of Molecular Sciences. 2020; 21(6):2130.
https://doi.org/10.3390/ijms21062130
Chicago/Turabian Style
Mendoza-Rodríguez, Mónica G., C. Ángel Sánchez-Barrera, Blanca E. Callejas, Verónica García-Castillo, Diana L. Beristain-Terrazas, Norma L. Delgado-Buenrostro, Yolanda I. Chirino, Sonia A. León-Cabrera, Miriam Rodríguez-Sosa, Emma Bertha Gutierrez-Cirlos,
and et al. 2020. "Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis" International Journal of Molecular Sciences 21, no. 6: 2130.
https://doi.org/10.3390/ijms21062130
APA Style
Mendoza-Rodríguez, M. G., Sánchez-Barrera, C. Á., Callejas, B. E., García-Castillo, V., Beristain-Terrazas, D. L., Delgado-Buenrostro, N. L., Chirino, Y. I., León-Cabrera, S. A., Rodríguez-Sosa, M., Gutierrez-Cirlos, E. B., Pérez-Plasencia, C., Vaca-Paniagua, F., Meraz-Ríos, M. A., & Terrazas, L. I.
(2020). Use of STAT6 Phosphorylation Inhibitor and Trimethylglycine as New Adjuvant Therapies for 5-Fluorouracil in Colitis-Associated Tumorigenesis. International Journal of Molecular Sciences, 21(6), 2130.
https://doi.org/10.3390/ijms21062130